Gene · 5469
Papers2,516
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,516
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Non-Coding RNA Journal Club: Highlights on Recent Papers-14. | Noncoding RNA | 2025 | 41283330 | PubTator, text mining | PubMed |
| MED1-driven ecDNA super-enhancers in cancer. | Cancer Cell | 2025 | 41237767 | PubTator, text mining | PubMed |
| Sequence-based prediction of condensate composition reveals that specificity can emerge from multivalent interactions among disordered regions. | Commun Chem | 2025 | 41083871 | PubTator, text mining | PubMed |
| In Silico Study of Natural Polyphenols as Potential Metabolic Modulators in Mitigating Lipotoxicity in Non-Alcoholic Fatty Liver Disease via Thyroid Hormone Receptor Alpha Activation. | Curr Issues Mol Biol | 2025 | 41020899 | PubTator, text mining | PubMed |
| Nuclear FGF2 orchestrates phase separation-mediated rDNA chromatin architecture to control BMSCs cell fate. | Bone Res | 2025 | 40993129 | PubTator, text mining | PubMed |
| Genomic Landscapes of Endometrioid and Mucinous Ovarian Cancers and Morphologically Similar Tumor Types. | Cancer Res Commun | 2025 | 40981433 | PubTator, text mining | PubMed |
| Extrachromosomal DNA associates with nuclear condensates and reorganizes chromatin structures to enhance oncogenic transcription. | Cancer Cell | 2025 | 40972571 | PubTator, text mining | PubMed |
| Real-time visualization of reconstituted transcription reveals RNAPII activation mechanisms at single promoters. | Cell Rep | 2025 | 40914943 | PubTator, text mining | PubMed |
| Interconnected study of molecular pathways: miR-137 as a central element at the intersection of lipid metabolism and prostate carcinogenesis. | Einstein (Sao Paulo) | 2025 | 40900470 | PubTator, text mining | PubMed |
| G-quadruplex-dependent transcriptional regulation by molecular condensation in the Bcl3 promoter. | Nucleic Acids Res | 2025 | 40884402 | PubTator, text mining | PubMed |
| Biomolecular phase separation in tumorigenesis: from aberrant condensates to therapeutic vulnerabilities. | Mol Cancer | 2025 | 40849651 | PubTator, text mining | PubMed |
| Integrative molecular network analysis of genetic risk factors to infer biomarkers and therapeutic targets for rheumatoid arthritis. | PLoS One | 2025 | 40839671 | PubTator, text mining | PubMed |
| MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines. | Cell Mol Life Sci | 2025 | 40833497 | PubTator, text mining | PubMed |
| A phosphorylation switch in the Mediator MED15 controls cellular senescence and cognitive decline. | Cell Discov | 2025 | 40825935 | PubTator, text mining | PubMed |
| Biomolecular Condensates as Emerging Biomaterials: Functional Mechanisms and Advances in Computational and Experimental Approaches. | Adv Mater | 2025 | 40801528 | PubTator, text mining | PubMed |
| RACK7 senses and fine-tunes enhancer activity. | iScience | 2025 | 40734674 | PubTator, text mining | PubMed |
| Deep Proteomics Analysis Unravels the Molecular Signatures of Tonsillar B Cells in PFAPA and OSAS in the Pediatric Population. | Int J Mol Sci | 2025 | 40724870 | PubTator, text mining | PubMed |
| Regulation of inflammatory responses by pH-dependent transcriptional condensates. | Cell | 2025 | 40680734 | PubTator, text mining | PubMed |
| Sequence-based prediction of condensate composition reveals that specificity can emerge from multivalent interactions among disordered regions. | bioRxiv | 2025 | 40667294 | PubTator, text mining | PubMed |
| [Multi-omics Mendelian randomization study on the causality between non-ionizing radiation and facial aging]. | Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi | 2025 | 40588408 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5469/papers?page=3